Skip to main content

Molecular Mechanism of Sleep–Wake Regulation: From Basic to Translational Research

  • Chapter
  • First Online:
Somatization and Psychosomatic Symptoms
  • 2141 Accesses

Abstract

Sleep gives our body its needed rest, which prepares us for the next day’s activities. In our modern society, people suffer from sleep deprivation, which leads to an inability to concentrate, to a loss of judgment, and to an increased risk of accidents. It is reported that 1 in 4–5 Japanese has a sleep problem and that 1 in 9 Japanese uses sleeping pills regularly. Hypnotic drugs are prescribed for insomnia patients. The current sleeping pills developed from tranquilizers are much safer than the ones used in the past, as the latter were developed from anesthetic agents, which brought death in case too many pills were taken. However, the current type of sleeping pills causes a coma in case of an overdose. Such pills are sometimes used in crimes such as coma robbery cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Narumiya, S., Ogorochi, T., Nakao, K., et al. (1982). Prostaglandin D2 in rat brain, spinal cord and pituitary: Basal level and regional distribution. Life Sciences, 31, 2093–2103.

    Article  PubMed  Google Scholar 

  2. Ogorochi, T., Narumiya, S., Mizuno, N., et al. (1984). Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. Journal of Neurochemistry, 43, 71–82.

    Article  PubMed  Google Scholar 

  3. Ueno, R., Ishikawa, Y., Nakayama, T., et al. (1982). Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochemical and Biophysical Research Communications, 109, 576–582.

    Article  PubMed  Google Scholar 

  4. Onoe, H., Ueno, R., Fujita, I., et al. (1988). Prostaglandin D2, a cerebral sleep-inducing substance in monkeys. Proceedings of the National Academy of Sciences of the United States of America, 85, 4082–4086.

    Article  PubMed  Google Scholar 

  5. Roberts, L. J., Sweetman, B. J., Lewis, R. A., et al. (1980). Increased production of prostaglandin D2 in patients with systemic mastocytosis. The New England Journal of Medicine, 303, 1400–1404.

    Article  PubMed  Google Scholar 

  6. Pentreath, V. W., Rees, K., Owolabi, O. A., et al. (1990). The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 795–799.

    Article  PubMed  Google Scholar 

  7. Kohtoh, S., Taguchi, Y., Matsumoto, N., et al. (2008). Algorithm for sleep scoring in experimental animals based on fast Fourier transform power spectrum analysis of the electroencephalogram. Sleep and Biological Rhythms, 6, 163–171.

    Article  Google Scholar 

  8. Mizoguchi, A., Eguchi, N., Kimura, K., et al. (2001). Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proceedings of the National Academy of Sciences of the United States of America, 98, 11674–11679.

    Article  PubMed  Google Scholar 

  9. Qu, W. M., Huang, Z. L., Xu, X. H., et al. (2006). Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proceedings of the National Academy of Sciences of the United States of America, 103, 17949–17954.

    Article  PubMed  Google Scholar 

  10. Huang, Z. L., Qu, W. M., Eguchi, N., et al. (2005). Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nature Neuroscience, 8, 858–859.

    Article  PubMed  Google Scholar 

  11. Lazarus, M., Shen, H. Y., Cherasse, Y., et al. (2011). Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. Journal of Neuroscience, 31, 10067–10075.

    Article  PubMed  Google Scholar 

  12. Makino, Y., Kondo, S., Nishimura, Y., et al. (2009). Hastatoside and verbenalin are sleep-promoting components in Verbena officinalis. Sleep and Biological Rhythms, 7, 211–217.

    Article  Google Scholar 

  13. Qiu, M. H., Qu, W. M., Xu, X. H., et al. (2009). D1/D2 receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacology, Biochemistry and Behavior, 94, 16–23.

    Article  Google Scholar 

  14. Omori, K., Kagami, Y., Yokoyama, C., et al. (2012). Promotion of non-rapid eye movement sleep in mice after oral administration of ornithine. Sleep and Biological Rhythms, 10, 38–45.

    Article  Google Scholar 

  15. Masaki, M., Aritake, K., Tanaka, H., et al. (2012). Crocin promotes non-rapid eye movement sleep in mice. Molecular Nutrition & Food Research, 56, 304–308.

    Article  Google Scholar 

  16. Liu, Z., Xu, X. H., Liu, T. Y., et al. (2012). Safranal enhances non-rapid eye movement sleep in pentobarbital-treated mice. CNS Neuroscience & Therapeutics. 18, 623–630.

    Google Scholar 

  17. Qu, W. M., Yue, X. F., Sun, Y., et al. (2012). Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABAA receptor in mice. British Journal of Pharmacology. 167, 587–598.

    PubMed  Google Scholar 

  18. Chen, C., Zhou, X., Luo, Y., et al. (2012). Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABAA receptor in mice. Neuropharmacology. 63, 1191–1199.

    Google Scholar 

Download references

Acknowledgments

We thank Drs. Michael Lazarus and Zhi-Li Huang for helpful comments on this manuscript. This work was supported by grants from the Japan Society for the Promotion of Science, Japan Science and Technology Agency, Takeda Science Foundation, Sankyo Foundation, the Program of Basic and Applied Researches for Innovations in Bio-oriented Industry of Japan, Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd, and Osaka City.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihiro Urade Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Urade, Y. (2013). Molecular Mechanism of Sleep–Wake Regulation: From Basic to Translational Research. In: Koh, K. (eds) Somatization and Psychosomatic Symptoms. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7119-6_6

Download citation

Publish with us

Policies and ethics